Metropolitan Life Insurance Company (MetLife)’s Aerie Pharmaceuticals AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-2,986
| Closed | -$45.2K | – | 2385 |
|
|
2022
Q3 | $45.2K | Hold |
2,986
| – | – | ﹤0.01% | 1526 |
|
|
2022
Q2 | $22.4K | Hold |
2,986
| – | – | ﹤0.01% | 1994 |
|
|
2022
Q1 | $27.2K | Sell |
2,986
-8,759
| -75% | -$67.5K | ﹤0.01% | 1944 |
|
|
2021
Q4 | $82.5K | Sell |
11,745
-37
| -0.3% | -$387 | ﹤0.01% | 2576 |
|
|
2021
Q3 | $134K | Hold |
11,782
| – | – | ﹤0.01% | 2351 |
|
|
2021
Q2 | $189K | Buy |
11,782
+712
| +6% | +$12.2K | ﹤0.01% | 2189 |
|
|
2021
Q1 | $198K | Sell |
11,070
-1,141
| -9% | -$19.7K | ﹤0.01% | 2025 |
|
|
2020
Q4 | $165K | Sell |
12,211
-799
| -6% | -$9.65K | ﹤0.01% | 2061 |
|
|
2020
Q3 | $153K | Sell |
13,010
-1,054
| -7% | -$12.8K | ﹤0.01% | 1947 |
|
|
2020
Q2 | $208K | Hold |
14,064
| – | – | ﹤0.01% | 1769 |
|
|
2020
Q1 | $190K | Hold |
14,064
| – | – | ﹤0.01% | 1617 |
|
|
2019
Q4 | $340K | Hold |
14,064
| – | – | 0.01% | 1561 |
|
|
2019
Q3 | $270K | Buy |
14,064
+1,956
| +16% | +$44.8K | ﹤0.01% | 1669 |
|
|
2019
Q2 | $358K | Buy |
12,108
+532
| +5% | +$20.5K | 0.01% | 1508 |
|
|
2019
Q1 | $550K | Hold |
11,576
| – | – | 0.01% | 1240 |
|
|
2018
Q4 | $418K | Hold |
11,576
| – | – | 0.01% | 1304 |
|
|
2018
Q3 | $713K | Hold |
11,576
| – | – | 0.01% | 1122 |
|
|
2018
Q2 | $782K | Buy |
11,576
+877
| +8% | +$49.1K | 0.01% | 1051 |
|
|
2018
Q1 | $580K | Buy |
10,699
+144
| +1% | +$8.05K | 0.01% | 1178 |
|
|
2017
Q4 | $631K | Sell |
10,555
-11,289
| -52% | -$685K | 0.01% | 1126 |
|
|
2017
Q3 | $1.06M | Buy |
21,844
+1,123
| +5% | +$61.3K | 0.01% | 1211 |
|
|
2017
Q2 | $1.09M | Hold |
20,721
| – | – | 0.01% | 1198 |
|
|
2017
Q1 | $940K | Hold |
20,721
| – | – | 0.01% | 1263 |
|
|
2016
Q4 | $784K | Buy |
20,721
+2,828
| +16% | +$107K | 0.01% | 1435 |
|
|
2016
Q3 | $675K | Hold |
17,893
| – | – | ﹤0.01% | 1513 |
|
|
2016
Q2 | $315K | Buy |
17,893
+2,544
| +17% | +$41.2K | ﹤0.01% | 2003 |
|
|
2016
Q1 | $187K | Hold |
15,349
| – | – | ﹤0.01% | 2218 |
|
|
2015
Q4 | $374K | Hold |
15,349
| – | – | ﹤0.01% | 1827 |
|
|
2015
Q3 | $272K | Hold |
15,349
| – | – | ﹤0.01% | 2047 |
|
|
2015
Q2 | $271K | Buy |
+15,349
| New | +$281K | ﹤0.01% | 2188 |
|
|
2015
Q1 | – | Sell |
-9,028
| Closed | -$264K | – | 2491 |
|
|
2014
Q4 | $264K | Hold |
9,028
| – | – | ﹤0.01% | 2215 |
|
|
2014
Q3 | $187K | Buy |
9,028
+470
| +5% | +$9.27K | ﹤0.01% | 2424 |
|
|
2014
Q2 | $212K | Buy |
+8,558
| New | +$148K | ﹤0.01% | 2472 |
|
Metropolitan Life Insurance Company (MetLife)'s AERI Position: Q4 2022 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 2,986 shares — an estimated $45.2K sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in AERI in Q2 2014 and held it in 33 quarters. The position peaked at $1.09M in Q2 2017. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 2,986 Aerie Pharmaceuticals shares in Q4 2022, an estimated $45.2K.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Aerie Pharmaceuticals in Q2 2014 and held it in 33 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Aerie Pharmaceuticals position peaked at $1.09M in Q2 2017.
- 0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2022, filed 15 Feb 2023.